Embecta Corp (EMBC)
$19.65 -$0.27 (-1.36%) 12:07 PM 12/12/24
NASDAQ | $USD | Medical Instruments & SuppliesStock Data
-
Market Cap
$1.11B -
Day's Range
$19.47 - $20.30 -
Volume
560,552 -
52 Week Low / High
$9.63 - $21.32 -
PE Ratio
14.36x -
PEG Ratio
- -
Dividend Frequency
quarterly
EMBC's Dividend
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 3
- Hold
- 1
- Sell
- 1
- Strong Sell
- $16.00
- Target Price
Company News
-
Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company — Jul 29th, 2024
Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector NEW YORK, July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, has been...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$